-- 英國能源安全與淨零排放部週四表示,3月英國新增太陽能裝置量超過2.7萬套,總裝置容量突破200萬套,年新增裝置量達2.3吉瓦。 該部門表示,隨著英國政府在地緣政治緊張局勢後加快減少對波動較大的化石燃料市場的依賴,英國各地家庭正越來越多地採用太陽能。 該部門補充說,2026年3月,英國新增太陽能裝置量超過2.7萬套,創下自2012年以來的最高月裝機量,並使總裝機量突破200萬套大關。 該部門表示,太陽能裝置容量年增11.7%,新增2.3吉瓦國內再生能源發電量,增強了英國本地發電能力。 該部門表示,政府將繼續在住宅、教育和社區領域擴大太陽能部署,以降低能源成本並支持其清潔能源策略。 該部門補充說,當局已批准斯普林韋爾太陽能發電場項目,該項目預計將成為英國歷史上最大的太陽能項目。同時,政府也將在數月內推進家用即插即用太陽能板的推廣。 該部門表示,政府還強制要求英格蘭的新房屋安裝太陽能板,旨在擴大分散式發電規模並降低長期能源支出。 該部門引述國家能源系統營運商的數據稱,本月英國電網的太陽能發電量首次超過15吉瓦,反映出再生能源併網速度加快。 該部門表示,政府正透過「英國能源計畫」(Great British Energy)擴大屋頂太陽能的部署,今年將支持100所中小學和學院安裝太陽能係統。 該部門還補充說,政府將向社會住宅基金額外撥款1億歐元(約1.173億美元),目標是在本財年為多達5.7萬戶家庭安裝新的太陽能係統。 「這是我們清潔能源使命的實踐,幫助家庭應對全球能源衝擊,降低能源帳單,並推動英國擺脫化石燃料,」能源大臣艾德·米利班德說。
Related Articles
ManpowerGroup Sells Jefferson Wells US Business to Sikich
ManpowerGroup (MAN) said Thursday it is selling its Jefferson Wells US business to Sikich in a transaction valued at $100 million.ManpowerGroup will recognize a gain on sale in Q2, the company said, adding that the transaction closed on Thursday.The company will receive net cash proceeds at closing of approximately $88 million after working capital and other items, and it plans to use the proceeds to strengthen its balance sheet, according to a statement.Price: $30.40, Change: $-0.28, Percent Change: -0.91%
Sector Update: Financial Stocks Advance Thursday Afternoon
Financial stocks were higher Thursday afternoon, with the NYSE Financial Index rising 0.8% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.3%.The Philadelphia Housing Index was up 1.1%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1%.Bitcoin (BTC-USD) rose 0.6% to $76,227, and the yield for 10-year US Treasuries was decreasing 2.4 basis points to 4.39%.In economic news, the core personal consumption expenditures price index, the Federal Reserve's preferred inflation gauge, rose to 3.2% year-on-year in March from 3%, meeting expectations. It climbed 0.3% month-over-month, down from the 0.4% reported in February.US economic growth, measured by gross domestic product, rose by 2.0% in Q1 after a 0.5% gain in Q4, slower than a 2.3% increase expected in a survey compiled by Bloomberg.US initial jobless claims fell to 189,000 in the week ended April 25 from an upwardly revised 215,000 in the previous week, against expectations for a rise to 212,000 in a Bloomberg survey.In sector news, the US Senate unanimously passed Thursday a rule prohibiting its members from trading on prediction markets, effective immediately, CNBC reported.In corporate news, KKR (KKR) is considering selling the Flora Food Group spreads business, seeking to strike a deal at a valuation of up to $10 billion, the Financial Times reported. KKR shares climbed 4.2%.Mastercard's (MA) Q1 results outpaced Wall Street's estimates, but the company said that the Middle East conflict was impacting spending on cross-border travel. Its shares fell 4.7%.Brookfield Asset Management (BAM) is preparing to file draft documents as early as May for an initial public offering of Indian telecommunications tower operator Altius Telecom Infrastructure Trust, Bloomberg reported. Brookfield shares rose 3.9%.
Research Alert: CFRA Maintains Buy Rating On Shares Of The Cigna Group
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target to $330 from $320, based on a 10.9x multiple of our 2026 EPS estimate, near CI's five-year historical forward average of 11.2x. We think CI's multiple balances pharmaceutical business momentum in CI's Evernorth segment and a timely portfolio shift toward more commercial exposure, offset by near-term challenges around higher medical costs across the managed care space. We raise our 2026 EPS estimate by $0.01 to $30.35 and lower 2027's by $0.09 to $33.42. Following Q1 results that beat consensus views, CI's annual Medical Care Ratio (MCR) guidance was maintained at 83.7% to 84.7% for 2026, suggesting cost discipline within a challenging operating environment for managed care. The company plans to exit the Individual ACA Exchange market by year-end 2026, citing the relatively small exposure relative to other parts of CI's portfolio and challenges with meaningfully scaling operations.